Rockefeller Capital Management L.P. Ginkgo Bioworks Holdings, Inc. Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $80,614 - $127,005	76,051 Added 16.04%	550,141 $638,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $16,998 - $24,148	13,491 Added 2.93%	474,090 $801,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $101,597 - $160,284	63,104 Added 15.88%	460,599 $833,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $110,772 - $189,479	-97,169 Reduced 19.64%	397,495 $739,000
Q1 2023 May 17, 2023	BUY	$1.2 - $2.19 $355 - $648	296 Added 0.06%	494,664 $657,000
Q4 2022 Mar 06, 2023	SELL	$1.63 - $3.52 $156,672 - $338,335	-96,118 Reduced 16.28%	494,368 $834,000
Q3 2022 Nov 02, 2022	SELL	$0.73 - $3.74 $13,493 - $69,130	-18,484 Reduced 3.04%	590,486 $1.84 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $118,069 - $225,405	53,668 Added 9.66%	608,970 $1.45 Million
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $437,942 - $1.34 Million	154,750 Added 38.63%	555,302 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $1.13 Million - $2.02 Million	135,671 Added 51.22%	400,552 $3.33 Million
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $2.42 Million - $3.52 Million	264,881 New	264,881 $3.07 Million

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.